[Treatment of parkinsonism and other extrapyramidal syndromes with a new thioxanthene derivative, Tremaril, as evaluated using Schwab's Parkinson Evaluation Sheet].
D000293:Adolescent; D000328:Adult; D000368:Aged; D001927:Brain Diseases / Q000188:drug therapy; D002749:Chlorprothixene / Q000627:therapeutic use*; D004576:Electromyography; D005116:Extrapyramidal Tracts; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000188:drug therapy*
D002749:Chlorprothixene